Cambridge, MA, United States of America

William Caffry

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Evelo Biosciences, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Caffry. Retrieved from https://idiyas.com/inventor/william-caffry

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of William Caffry

Introduction

William Caffry is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on compositions and methods that utilize specific therapeutic agents to combat cancer.

Latest Patents

Caffry holds a patent for "Compositions and methods of treating cancer using ssp." This patent outlines methods and compositions related to ssp, which are useful as therapeutic agents in the treatment of cancer. His innovative approach has the potential to impact cancer therapies significantly.

Career Highlights

Caffry is currently associated with Evelo Biosciences, Inc., where he continues to advance his research in cancer treatment. His dedication to innovation in this critical field showcases his commitment to improving patient outcomes.

Collaborations

Caffry has collaborated with esteemed colleagues such as Humphrey Gardner and Hank Wu. These partnerships enhance the research environment and foster the development of groundbreaking therapeutic solutions.

Conclusion

William Caffry's contributions to cancer treatment through his patent and work at Evelo Biosciences, Inc. highlight his role as an influential inventor in the medical field. His innovative methods and collaborations are paving the way for advancements in cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…